These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8032470)

  • 1. Clinical trials and the evaluation of new periodontitis therapies.
    Paquette DW; Fiorellini JP
    Curr Opin Periodontol; 1994; ():87-98. PubMed ID: 8032470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pocket depth reduction as an outcome measure of inflammation and soft tissue changes in periodontitis trials.
    Paquette DW
    J Int Acad Periodontol; 2005 Oct; 7(4 Suppl):147-56. PubMed ID: 16248271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems in the conduct and analysis of randomized clinical trials. Are we getting the right answers to the wrong questions?
    Rabeneck L; Viscoli CM; Horwitz RI
    Arch Intern Med; 1992 Mar; 152(3):507-12. PubMed ID: 1546913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment.
    Licciardone JC; Russo DP
    J Am Osteopath Assoc; 2006 Aug; 106(8):457-63. PubMed ID: 16943515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of efficacy outcome variables for the evaluation of periodontal disease treatment.
    Page RC
    J Int Acad Periodontol; 2005 Oct; 7(4 Suppl):139-46. PubMed ID: 16248270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial design in systemic lupus erythematosus.
    Dall'Era M; Wofsy D
    Curr Opin Rheumatol; 2006 Sep; 18(5):476-80. PubMed ID: 16896285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological issues of randomized controlled trials for the evaluation of reproductive health interventions.
    Villar J; Carroli G
    Prev Med; 1996; 25(3):365-75. PubMed ID: 8781015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent design and conduct of clinical trials.
    Yusuf S; Bosch J
    Clin Trials; 2006; 3(6):503-7. PubMed ID: 17170033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: II. Participant samples and assessment.
    Del Boca FK; Darkes J
    Addiction; 2007 Aug; 102(8):1194-203. PubMed ID: 17511752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is proper methodology associated with the use of a clinically relevant outcome measure? The case of randomized clinical trials on medical treatment of open-angle glaucoma.
    Rossetti L; Marchetti I; Orzalesi N; Scorpiglione N; Liberati A
    Online J Curr Clin Trials; 1993 Nov; Doc No 100():[6512 words; 199 paragraphs]. PubMed ID: 8305993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of treatment outcome.
    Fuller RK
    Alcohol Alcohol Suppl; 1991; 1():519-22. PubMed ID: 1845591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: I. Treatment implementation and research design.
    Del Boca FK; Darkes J
    Addiction; 2007 Jul; 102(7):1047-56. PubMed ID: 17567393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.